CANLYTx™ (CANCER + ANALYTICS) is a molecular data analytics and simulation engine that explores the whole exome data of the patient’s tumor DNA to demystify the complex genomic anomalies unique to that cancer. An individualized treatment regimen based on these genomic findings is presented in a detailed report to the clinicians.